| 000 | 01565 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250511202614.0 | ||
| 264 | 0 | _c19920318 | |
| 008 | 199203s 0 0 eng d | ||
| 022 | _a1660-8151 | ||
| 024 | 7 |
_a10.1159/000186697 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMorinière, P | |
| 245 | 0 | 0 |
_aControl of predialytic hyperphosphatemia by oral calcium acetate and calcium carbonate. Comparable efficacy for half the dose of elemental calcium given as acetate without lower incidence of hypercalcemia. _h[electronic resource] |
| 260 |
_bNephron _c1992 |
||
| 300 |
_a6-11 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aAcetates _xadministration & dosage |
| 650 | 0 | 4 | _aAcetic Acid |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCalcium Carbonate _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypercalcemia _xepidemiology |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPhosphates _xblood |
| 700 | 1 | _aDjerad, M | |
| 700 | 1 | _aBoudailliez, B | |
| 700 | 1 | _ael Esper, N | |
| 700 | 1 | _aBoitte, F | |
| 700 | 1 | _aWesteel, P F | |
| 700 | 1 | _aCompagnon, M | |
| 700 | 1 | _aBrazier, M | |
| 700 | 1 | _aAchard, J M | |
| 700 | 1 | _aFournier, A | |
| 773 | 0 |
_tNephron _gvol. 60 _gno. 1 _gp. 6-11 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000186697 _zAvailable from publisher's website |
| 999 |
_c1744812 _d1744812 |
||